These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11338859)

  • 21. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in drug therapy for peptic ulcer disease.
    Pappas TN; Mulvihill SJ; Goto Y; Debas HT
    Arch Surg; 1987 Apr; 122(4):447-50. PubMed ID: 2882741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of gastric acid secretion and therapeutic results: is there any correlation?
    Corinaldesi R; Ghidini C; Ricci Maccarini M; Santaguida P; Fratesi E; Barbara G; Stanghellini V
    Ital J Gastroenterol; 1990; 22 Suppl 1():2-4. PubMed ID: 1983421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients?
    Namiot Z; Stasiewicz J; Markowski AR; Namiot DB; Jaroszewicz W; Kemona A; Górski J
    Rocz Akad Med Bialymst; 2004; 49():75-9. PubMed ID: 15631318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Famotidine--a new histamine H2 receptor blockader].
    Grigor'ev PIa; Isakov VA; Iakovenko EP; Davydov SM; Vasil'eva ZI
    Klin Med (Mosk); 1991 Apr; 69(4):23-8. PubMed ID: 1865643
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of grandaxine in the treatment of patients with erosive-ulcerative stomach and gastroduodenal lesions].
    Vakhrushev IaM; Belova EV; Efremova LI
    Eksp Klin Gastroenterol; 2004; (4):21-4. PubMed ID: 15568662
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Evseev MA; Ivakhov GB; Golovin RA
    Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease].
    Vakhrushev IaM; Muravtseva OV
    Ter Arkh; 2006; 78(2):35-8. PubMed ID: 16613094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficiency of quamatel in combination with device sound stimulation of the gastroduodenal zone in ulcer patients].
    Maev IV; Samsonov A; Val'tova ED; Ismailova MZ; Ovchinnikova NI
    Klin Med (Mosk); 2001; 79(8):51-5. PubMed ID: 11588788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intragastric pH-metry, atropine test, and electrolyte content in the gastric juice in peptic ulcer].
    Orlikov GA; Makena VD; Erenshteĭn RKh
    Ter Arkh; 1981; 53(10):52-4. PubMed ID: 7313965
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of mild irritants on gastric outputs of bicarbonates and pepsinogen depends on the rate of acid secretion].
    Zolotarev VA; Andreeva IuV; Khropycheva RP
    Ross Fiziol Zh Im I M Sechenova; 2012 Jun; 98(6):744-56. PubMed ID: 23013012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion.
    Rune S
    Digestion; 1992; 51 Suppl 1():11-6. PubMed ID: 1397740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
    Thomson AB
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP; Johnston BT; Just RJ; Castell DO
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
    Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
    Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stressfulness of gastric juice].
    Amirov NSh; Antonov DV
    Biull Eksp Biol Med; 1981 Mar; 91(3):300-3. PubMed ID: 7018614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.